Fluoride effects: The two faces of janus

Current Medicinal Chemistry

Volumn 17, Issue 22, 2010, Pages 2431-2441

  Gazzano, E ^a   Bergandi, L ^a   Riganti, C ^a   Aldieri, E ^a   Doublier, S ^a   Costamagna, C ^a   Bosia, A ^a   Ghigo, D ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bone density; Caries; Fluoride; Fluorosis; G proteins; Oxidative stress; Tyrosine phosphorylation

Indexed keywords

ALUMINUM FLUORIDE; AMELOGENIN; FLUORAPATITE; FLUORIDE; FLUORIDE SODIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOTRANSFERASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; TITANIUM;

ACIDOSIS; ARTICLE; DENTAL CARE; DENTAL CARIES; DIARRHEA; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FLUORIDATION; FLUOROSIS; FRAGILITY FRACTURE; HEART ARRHYTHMIA; HUMAN; HYDROLYSIS; LIPID PEROXIDATION; NAUSEA; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; OXIDATIVE STRESS; PAGET BONE DISEASE; PROTEIN PHOSPHORYLATION; RNA TRANSCRIPTION; VOMITING;

ANIMALS; DENTAL CARIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORIDES; HUMANS;

EID: 77955634128     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791698503     Document Type: Article

References (134)

1. Bergman, C.; Gray-Scott, D.; Chen, J.J.; Meacham, S. What is next for the dietary reference intakes for bone metabolism related nutrients beyond calcium: phosphorus, magnesium, vitamin D, and fluoride? Crit. Rev. Food Sci. Nutr., 2009, 49, 136-144.
2. Chouhan, S.; Flora, S.J. Effects of fluoride on the tissue oxidative stress and apoptosis in rats: biochemical assays supported by IR spectroscopy data. Toxicology, 2008, 254, 61-67.
3. DenBesten, P.K. Biological mechanisms of dental fluorosis relevant to the use of fluoride supplements. Commun. Dent. Oral Epidemiol., 1999, 27, 41-47.
4. Marquis, R.E.; Clock, S.A.; Mota-Meira, M. Fluoride and organic weak acids as modulators of microbial physiology. FEMS Microbiol. Rev., 2003, 26, 493-510.
5. ADA reports. Position of the American Dietetic Association: the impact of fluoride on health. J. Am. Diet. Assoc., 2000, 100, 1208-1213.
6. International Programme on Chemical Safety. Environmental Health Criteria for Fluorides (EHC 227), World Health Organization: Geneva, 2002.
7. Suma Latha, S.; Ambika, S.R.; Prasad, S.J. Fluoride contamination status of ground water in Karnataka. Curr. Sci., 1999, 6, 730-734.
8. Ortiz-Pérez, D.; Rodríguez-Martínez, M.; Martínez, F.; Borja-Aburto, V.H.; Castelo, J.; Grimaldo, J.I.; de la Cruz, E.; Carrizales, L.; Díaz-Barriga, F. Fluoride-induced disruption of reproductive hormones in men. Environ. Res., 2003, 93, 20-30.
9. Reddy, G.B.; Khandare, A.L.; Reddy, P.Y.; Rao, G.S.; Balakrishna, N.; Srivalli, I. Antioxidant defense system and lipid peroxidation in patients with skeletal fluorosis and in fluoride-intoxicated rabbits. Toxicol. Sci., 2003, 72, 363-368.
10. Das, J.; Ghosh, J.; Manna, P.; Sil, P.C. Taurine provides antioxidant defense against NaF-induced cytotoxicity in murine hepatocytes. Pathophysiology, 2008, 15, 181-190.
11. Featherstone, J.D. Prevention and reversal of dental caries: role of low level fluoride. Commun. Dent. Oral Epidemiol., 1999, 27, 31-40.
12. Caverzasio, J.; Palmer, G.; Bonjour, J.P. Fluoride: Mode of action. Bone, 1998, 22, 585-589.
13. Robinson, C.; Connell, S.; Kirkham, J.; Brookes, S.J.; Shore, R.C.; Smith, A.M. The effect of fluoride on the developing tooth. Caries Res., 2004, 38, 268-276.
14. ten Cate, J.M. Current concepts on the theories of the mechanism of action of fluoride. Acta Odontol. Scand., 1999, 57, 325-329.
15. Li, L. The biochemistry and physiology of metallic fluoride: action, mechanism, and implications. Crit. Rev. Oral Biol. Med., 2003, 14, 100-114.
16. Bawden, J.W.; Crenshaw, M.A.; Wright, J.T.; LeGeros, R.Z. Considerations of possible biologic mechanisms of fluorosis. J. Dent. Res., 1995, 74, 1349-1352.
17. Kubota, K.; Lee, D.H.; Tsuchiya, M.; Young, C.S.; Everett, E.T.; Martinez-Mier, E.A.; Snead, M.L.; Nguyen, L.; Urano, F.; Bartlett, J.D. Fluoride induces endoplasmic reticulum stress in ameloblasts responsible for dental enamel formation. J. Biol. Chem., 2005, 280, 23194-23202.
18. Sharma, R.; Tsuchiya, M.; Bartlett, J.D. Fluoride induces endoplasmic reticulum stress and inhibits protein synthesis and secretion. Environ. Health Perspect., 2008, 116, 1142-1146.
19. Zhang, Y.; Yan, Q.; Li, W.; DenBesten, P.K. Fluoride downregulates the expression of matrix metalloproteinase-20 in human fetal tooth ameloblast-lineage cells in vitro. Eur. J. Oral Sci., 2006, 114, 105-110.
20. DenBesten, P.K.; Yan, Y.; Featherstone, J.D.; Hilton, J.F.; Smith, C.E.; Li, W. Effects of fluoride on rat dental enamel matrix proteinases. Arch. Oral Biol., 2002, 47, 763-770.
21. Browne, D.; Whelton, H.; O'Mullane, D. Fluoride metabolism and fluorosis. J. Dent., 2005, 33, 177-186.
22. Pizzo, G.; Piscopo, M.R.; Pizzo, I.; Giuliana, G. Community water fluoridation and caries prevention: a critical review. Clin. Oral Investig., 2007, 11, 189-193.
23. Steiner, D.M.; Steiner, G.G. Fluoride as an essential element in the prevention of disease. Med. Hypotheses, 2004, 62, 710-717.
24. Ismail, A.I.; Hasson, H. Fluoride supplements, dental caries and fluorosis: a systematic review. J. Am. Dent. Assoc., 2008, 139, 1457-1468.
25. Swan, E. Dietary fluoride supplement protocol for the new millennium. J. Can. Dent. Assoc., 2000, 66, 362-363.
26. Zimmer, S.; Jahn, K.R.; Barthel, C.R. Recommendations for the use of fluoride in caries prevention. Oral Health Prev. Dent., 2003, 1, 45-51.
27. Australian Research Centre for Population Oral Health. The use of fluorides in Australia: guidelines. Aust. Dent. J., 2006, 51, 195-199.
28. Yeung, C.A. A systematic review of the efficacy and safety of fluoridation. Evid. Based Dent., 2008, 9, 39-48.
29. Griffin, S.O.; Regnier, E.; Griffin, P.M.; Huntley, V. Effectiveness of fluoride in preventing caries in adults. J. Dent. Res., 2007, 86, 410-415.
30. Farley, J.R.; Wergedal, J.E.; Baylink, D.J. Fluoride directly stimulates proliferation and alkaline phosphatase activity of boneforming cells. Science, 1983, 222, 330-332.
31. Gruber, H.E.; Baylink, D.J. The effects of fluoride on bone. Clin. Orthop. Relat. Res., 1991, 267, 264-277.
32. Lau, K.H.; Baylink, D.J. Molecular mechanism of action of fluoride on bone cells. J. Bone Miner Res., 1998, 13, 1660-1667.
33. Riggs, B.L.; Seeman, E.; Hodgson, S.F. Effect of the fluoride/ calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N. Engl. J. Med., 1982, 306, 446-450.
34. Chavassieux, P.; Boivin, G.; Serre, C.M.; Meunier, P.J. Fluoride increases rat osteoblast function and population after in vivo administration but not after in vitro exposure. Bone, 1993, 14, 721-725.
35. Kopp, J.B.; Robey, P.G. Sodium fluoride does not increase human bone cell proliferation or protein synthesis in vitro. Calcif. Tissue Int., 1990, 47, 221-229.
36. Kassem, M.; Mosekilde, L.; Eriksen, E.F. Effects of fluoride on human bone cells in vitro: differences in responsiveness between stromal osteoblast precursors and mature osteoblasts. Eur. J. Endocrinol., 1994, 130, 381-386.
37. Xu, H.; Wang, C.H.; Zhao, Z.T.; Zhang, W.B.; Li, G.S. Role of oxidative stress in osteoblasts exposed to sodium fluoride. Biol. Trace Elem. Res., 2008, 123, 109-115.
38. Waddington, R.J.; Langley, M.S. Altered expression of matrix metalloproteinases within mineralizing bone cells in vitro in the presence of fluoride. Connect Tissue Res., 2003, 44, 88-95.
39. Wurtz, T.; Houari, S.; Mauro, N.; MacDougall, M.; Peters, H.; Berdal, A. Fluoride at non-toxic dose affects odontoblast gene expression in vitro. Toxicology, 2008, 249, 26-34.
40. Avila, G.; Misch, K.; Galindo-Moreno, P.; Wang, H.L. Implant surface treatment using biomimetic agents. Implant. Dent., 2009, 18, 17-26.
41. Qu, H.; Wei, M. The effect of fluoride contents in fluoridated hydroxyapatite on osteoblast behavior. Acta Biomater., 2006, 2, 113-119.
42. Monjo, M.; Lamolle, S.F.; Lyngstadaas, S.P.; Rønold, H.J.; Ellingsen, J.E. In vivo expression of osteogenic markers and bone mineral density at the surface of fluoride-modified titanium implants. Biomaterials, 2008, 29, 3771-3780.
43. Avioli, L.V.; Berman, M. Role of magnesium metabolism and the effects of fluoride therapy in Paget's disease of bone. J. Clin. Endocrinol. Metab., 1968, 28, 700-710.
44. Ringe, J.D.; Rovati, L.C. Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates. Calcif. Tissue Int., 2001, 69, 252-255.
45. Dure-Smith, B.A.; Farley, S.M.; Linkhart, S.G.; Farley, J.R.; Baylink, D.J. Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation. J. Clin. Endocrinol. Metab., 1996, 81, 269-275.
46. Vestergaard, P.; Jorgensen, N.R.; Schwarz, P.; Mosekilde, L. Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis. Osteoporos. Int., 2008, 19, 257-268.
47. Turner, C.H.; Owan, I.; Brizendine, E.J.; Zhang, W.; Wilson, M.E.; Dunipace, A.J. High fluoride intakes cause osteomalacia and diminished bone strength in rats with renal deficiency. Bone, 1996, 19, 595-601.
48. Ghosh, D.; Das Sarkar, S.; Maiti, R.; Jana, D.; Das, U.B. Testicular toxicity in sodium fluoride treated rats: association with oxidative stress. Reprod. Toxicol., 2002, 16, 385-390.
49. Izquierdo-Vega, J.A.; Sánchez-Gutiérrez, M.; Del Razo, L.M. Decreased in vitro fertility in male rats exposed to fluoride-induced oxidative stress damage and mitochondrial transmembrane potential loss. Toxicol. Appl. Pharmacol., 2008, 230, 352-357.
50. Tang, Q.Q.; Du, J.; Ma, H.H.; Jiang, S.J.; Zhou, X.J. Fluoride and children's intelligence: a meta-analysis. Biol. Trace Elem. Res., 2008, 126, 115-120.
51. Long, Y.G.; Wang, Y.N.; Chen, J.; Jiang, S.F.; Nordberg, A.; Guan, Z.Z. Chronic fluoride toxicity decreases the number of nicotinic acetylcholine receptors in rat brain. Neurotoxicol. Teratol., 2002, 24, 751-757.
52. Chen, J.; Shan, K.R.; Long, Y.G.; Wang, Y.N.; Nordberg, A.; Guan, Z.Z. Selective decreases of nicotinic acetylcholine receptors in PC12 cells exposed to fluoride. Toxicology, 2003, 183, 235-242.
53. Kongerud, J.; Boe, J.; Søyseth, V.; Naalsund, A.; Magnus, P. Aluminium potroom asthma: the Norwegian experience. Eur. Respir. J., 1994, 7, 165-172.
54. Ando, M.; Tamura, K.; Katagiri, K. Study on suspended particulate matter and polycyclic aromatic hydrocarbons in indoor and outdoor air. Int. Arch. Occup. Environ. Health, 1991, 63, 297-301.
55. Søyseth, V.; Kongerud, J. Prevalence of respiratory disorders among aluminium potroom workers in relation to exposure to fluorides. Br. J. Ind. Med., 1992, 49, 125-130.
56. Viragh, E.; Viragh, H.; Laczka, J.; Coldea, V. Health effects of occupational exposure to fluorine and its compounds in a smallscale enterprise. Ind. Health, 2006, 44, 64-68.
57. Lund, K.; Refsnes, M.; Ramis, I.; Dunster, C.; Boe, J.; Schwarze, P.E.; Skovlund, E.; Kelly, F.J.; Kongerud, J. Human exposure to hydrogen fluoride induces acute neutrophilic, eicosanoid, and antioxidant changes in nasal lavage fluid. Inhal. Toxicol., 2002, 14, 119-132.
58. Hirano, S.; Ando, M.; Kanno, S. Inflammatory responses of rat alveolar macrophages following exposure to fluoride. Arch. Toxicol., 1999, 73, 310-315.
59. Yamamoto, S.; Katagiri, K.; Ando, M.; Chen, X.Q. Suppression of pulmonary antibacterial defenses mechanisms and lung damage in mice exposed to fluoride aerosol. J. Toxicol. Environ. Health A, 2001, 62, 485-494.
60. Hirano, S.; Ando, M. Apoptotic cell death following exposure to fluoride in rat alveolar macrophages. Arch. Toxicol., 1996, 70, 249-251.
61. Thrane, E.V.; Refsnes, M.; Thoresen, G.H.; Låg, M.; Schwarze, P.E. Fluoride-induced apoptosis in epithelial lung cells involves activation of MAP kinases p38 and possibly JNK. Toxicol. Sci., 2001, 61, 83-91.
62. Refsnes, M.; Schwarze, P.E.; Holme, J.A.; Låg, M. Fluorideinduced apoptosis in human epithelial lung cells (A549 cells): Role of different G protein-linked signal systems. Hum. Exp. Toxicol., 2003, 22, 111-123.
63. Refsnes, M.; Becher, R.; Låg, M.; Skuland, T.; Schwarze, P.E. Fluoride-induced interleukin-6 and interleukin-8 synthesis in human epithelial lung cells. Hum. Exp. Toxicol., 1999, 18, 645-652.
64. Higashijima, T.; Ferguson, K.M.; Sternweis, P.C.; Ross, E.M.; Smigel, M.D.; Gilman, A.G. The effect of activating ligands on the intrinsic fluorescence of guanine nucleotide-binding regulatory proteins. J. Biol. Chem., 1987, 262, 752-756.
65. Antonny, B.; Sukumar, M.; Bigay, J.; Chabre, M.; Higashijima, T. The mechanism of aluminum-independent G-protein activation by fluoride and magnesium. J. Biol. Chem., 1993, 268, 2393-2402.
66. Mittal, R.; Ahmadian, M.R.; Goody, R.S.; Wittinghofer, A. Formation of a transition-state analog of the Ras GTPase reaction by Ras- GDP, tetrafluoroaluminate, and GTPase-activating proteins. Science, 1996, 273, 115-117.
67. Graham, D.L.; Eccleston, J.F.; Chung, C.W.; Lowe, P.N. Magnesium fluoride-dependent binding of small G proteins to their GTPase-activating proteins. Biochemistry, 1999, 38, 14981-14987.
68. Vincent, S.; Settleman, J. Inhibition of RhoGAP activity is sufficient for the induction of Rho-mediated actin reorganization. Eur. J. Cell Biol., 1999, 78, 539-548.
69. Bogatcheva, N.V.; Wang, P.; Birukova, A.A.; Verin, A.D.; Garcia, J.G. Mechanism of fluoride-induced MAP kinase activation in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol., 2006, 290, L1139-L1145.
70. Wergedal, J.E.; Lau, K.H. Human bone cells contain a fluoridesensitive acid phosphatase: evidence that this enzyme functions at neutral pH as a phosphotyrosyl protein phosphatase. Clin. Biochem., 1992, 25, 47-53.
71. Lau, K.H.W.; Farley, J.R.; Freeman, T.K.; Baylink, D.J. A proposed mechanism of the mitogenic action of fluoride on bone cells. Inhibition of the activity of an osteoblastic acid phosphatase, Metabolism, 1989, 38, 858-868.
72. Lau, K.H.W.; Baylink, D.J. Osteoblastic tartrate-resistant acid phosphatase: its potential role in the molecular mechanism of osteogenic action of fluoride. J. Bone Miner. Res., 2003, 18, 1897-1900.
73. Thomas, A.B.; Hashimoto, H.; Baylink, D.J.; Lau, K.H. Fluoride at mitogenic concentrations increases the steady state phosphotyrosyl phosphorylation level of cellular proteins in human bone cells. J. Clin. Endocrinol. Metab., 1996, 81, 2570-2578.
74. mapk, in human TE85 osteosarcoma cells. J. Clin. Endocrinol. Metab., 1997, 82, 1126-1135.
75. Partanen, S. Inhibition of human renal acid phosphatases by nephrotoxic micromolar concentrations of fluoride. Exp. Toxicol. Pathol., 2002, 54, 231-237.
76. Caverzasio, J.; Palmer, G.; Suzuki, A.; Bonjour, J.P. Mechanism of the mitogenic effect of fluoride on osteoblast-like cells: evidences for a G protein-dependent tyrosine phosphorylation process. J. Bone Miner. Res., 1997, 12, 1975-1983.
77. Susa, M.; Standke, G.J.; Jeschke, M.; Rohner, D. Fluoroaluminate induces pertussis toxin-sensitive protein phosphorylation: differences in MC3T3-E1 osteoblastic and NIH3T3 fibroblastic cells. Biochem. Biophys. Res. Commun., 1997, 235, 680-684.
78. Jeschke, M.; Standke, G.J.; Scaronuscarona, M. Fluoroaluminate induces activation and association of Src and Pyk2 tyrosine kinases in osteoblastic MC3T3-E1 cells. J. Biol. Chem., 1998, 273, 11354-11361.
79. Viñals, F.; Testar, X.; Palacín, M.; Zorzano, A. Inhibitory effect of fluoride on insulin receptor autophosphorylation and tyrosine kinase activity. Biochem. J., 1993, 291, 615-622.
80. Li, L.; Fleming, N. Aluminum fluoride inhibits phospholipase D activation by a GTP-binding protein-independent mechanism. FEBS Lett., 1999, 458, 419-423.
81. Katada, T., Ui, M. ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J. Biol. Chem., 1982, 257, 7210-7216.
82. 2+ mobilization in C6 glioma cells. Neuroendocrinology, 1993, 57, 322-329.
83. Weber, L.P.; Chow, W.L.; Abebe, W.; MacLeod, K.M. Enhanced contractile responses of arteries from streptozotocin diabetic rats to sodium fluoride. Br. J. Pharmacol., 1996, 118, 115-122.
84. Zeng, Y.Y.; Benishin, C.G.; Pang, P.K.T. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. I. Studies with fluoride. J. Pharmacol. Exp. Ther., 1989, 250, 343-351.
85. Mermoud, J.E.; Cohen, P.; Lamond., A.I. Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing. Nucleic Acids Res., 1992, 20, 5263-5269.
86. Wang, P.; Verin, A.D.; Birukova, A.; Gilbert-McClain, L.I.; Jacobs, K.; Garcia, J.G. Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: role of MLC phosphorylation. Am. J. Physiol. Lung Cell. Mol. Physiol., 2001, 281, L1472-L1483.
87. Anderson, N.G.; Kilgour, E.; Sturgill, T.W. Activation of mitogenactivated protein kinase in BC3H1 by fluoroaluminate. J. Biol. Chem., 1991, 266, 10131-10135.
88. Heidenreich, O.; Neininger, A.; Schratt, G.; Zinck, R.; Cahill, M.A.; Engel, K.; Kotlyarov, A.; Kraft, R.; Kostka, S.; Gaestel, M.; Nordheim, A. MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J. Biol. Chem., 1999, 274, 14434-14443.
89. Lewis, T. S.; Shapiro, P. S.; Ahn, N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res., 1998, 74, 49-139.
90. Refsnes, M.; Skuland, T.; Schwarze, P.E.; Øvrevik, J.; Låg, M. Fluoride-induced IL-8 release in human epithelial lung cells: Relationship to EGF-receptor-, SRC- and MAP-kinase activation. Toxicol. Appl. Pharmacol., 2008, 227, 56-67.
91. Ridley, W.; Matsuoka, M. Fluoride-induced cyclooxygenase-2 expression and prostaglandin E2 production in A549 human pulmonary epithelial cells. Toxicol. Lett., 2009, 188, 180-185.
92. Kagawa, R.; Montgomery, M.G.; Braig, K.; Leslie, A.G.; Walker, J.E. The structure of bovine F1-ATPase inhibited by ADP and beryllium fluoride. EMBO J., 2004, 23, 2734-2744.
93. Ahmad, Z.; Senior, A.E. Inhibition of the ATPase activity of Escherichia coli ATP synthase by magnesium fluoride. FEBS Lett., 2006, 580, 517-520.
94. Sutton, S.V.; Bender, G.R.; Marquis, R.E. Fluoride inhibition of proton-translocating ATPases of oral bacteria. Infect. Immun., 1987, 55, 2597-2603.
95. Lunardi, J.; Dupuis, A.; Garin, J.; Issartel, J.P.; Michel, L.; Chabre, M.; Vignais, P.V. Inhibition of H+-transporting ATPase by formation of a tight nucleoside diphosphate-fluoroaluminate complex at the catalytic site. Proc. Natl. Acad. Sci. USA, 1988, 85, 8958-8962.
96. Burgstahler, A.W. Recent research on fluoride and oxidative stress. Fluoride, 2009, 42, 73-74.
97. Hirano, S.; Ando, M. Fluoride mediates apoptosis in osteosarcoma UMR 106 and its cytotoxicity depends on the pH. Arch. Toxicol., 1997, 72, 52-58.
98. García-Montalvo, E.A.; Reyes-Pérez, H.; Del Razo, L.M. Fluoride exposure impairs glucose tolerance via decreased insulin expression and oxidative stress. Toxicology, 2009, 263, 75-83.
99. Otsuki, S.; Morshed, S.R.; Chowdhury, S.A.; Takayama, F.; Satoh, T.; Hashimoto, K.; Sugiyama, K.; Amano, O.; Yasui, T.; Yokote, Y.; Akahane, K.; Sakagami, H. Possible link between glycolysis and apoptosis induced by sodium fluoride. J. Dent. Res., 2005, 84, 919-923.
100. Soni, M.G.; Kachole, M.S.; Pawar, S.S. Alterations in drug metabolising enzymes and lipid peroxidation in different rat tissues by fluoride. Toxicol. Lett., 1984, 21, 167-172.
101. Toper, R.; Aviram, A.; Aviram, I. Fluoride mediated activation of guinea pig neutrophils. Biochem. Biophys. Acta, 1987, 931, 262-266.
102. Guan, Z.Z.; Xiao, K.Q.; Zeng, X.Y.; Long, Y.G.; Cheng, Y.H.; Jiang, S.F.; Wang, Y.N. Changed cellular membrane lipid composition and lipid peroxidation of kidney in rats with chronic fluorosis. Arch. Toxicol., 2000, 74, 602-608.
103. Anuradha, C.D.; Kanno, S.; Hirano, S. Fluoride induces apoptosis by caspase-3 activation in human leukemia HL-60 cells. Arch. Toxicol., 2000, 74, 226-230.
104. Anuradha, C.D.; Kanno, S.; Hirano, S. Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluorideinduced apoptosis in HL-60 cells. Free Radic. Biol. Med., 2001, 31, 367-373.
105. Wang, A.G.; Xia, T.; Chu, Q.L.; Zhang, M.; Liu, F.; Chen, X.M.; Yang, K.D. Effects of fluoride on lipid peroxidation, DNA damage and apoptosis in human embryo hepatocytes. Biomed. Environ. Sci., 2004, 17, 217-222.
106. He, L.F.; Chen, J.G. DNA damage, apoptosis and cell cycle changes induced by fluoride in rat oral mucosal cells and hepatocytes. World J. Gastroenterol., 2006, 12, 1144-1148.
107. Shanthakumari, D.; Srinivasalu, S.; Subramanian, S. Effects of fluoride intoxication on lipid peroxidation and antioxidant status in experimental rats. Toxicology, 2004, 204, 219-228.
108. Mittal, M.; Flora, S.J.S. Effects of individual and combined exposure to sodium arsenite and sodium fluoride on tissue oxidative stress, arsenic and fluoride levels in male mice. Chem. Biol. Interact., 2006, 162, 128-139.
109. Zhan, X.A.; Wang, M.; Xu, Z.R.; Li, W.F.; Li, J.X. Evaluation of caspase-dependent apoptosis during fluoride-induced liver lesion in pigs. Arch. Toxicol., 2006, 80, 74-80.
110. Zhan, X.A.; Wang, M.; Xu, Z.R.; Li, W.F.; Li, J.X. Effects of fluoride on hepatic antioxidant system and transcription of Cu/Zn SOD gene in young pigs. J. Trace Elem. Med. Biol., 2006, 20, 83-87.
111. Zhang, M.; Wang, A.; He, W.; He, P.; Xu, B.; Xia, T.; Chen, X.; Yang, K. Effects of fluoride on the expression of NCAM, oxidative stress, and apoptosis in primary cultured hippocampal neurons. Toxicology, 2007, 236, 208-216.
112. Shan, K.R.; Qi, X.L., Long, Y.G., Nordberg, A.; Guan, Z.Z. Decreased nicotinic receptors in PC12 cells and rat brains influenced by fluoride toxicity--a mechanism relating to a damage at the level in post-transcription of the receptor genes. Toxicology, 2004, 200, 169-177.
113. Jin, X.Q.; Xu, H.; Shi, H.Y.; Zhang, J.M.; Zhang, H.Q. Fluorideinduced oxidative stress of osteoblasts and protective effects of baicalein against fluoride toxicity. Biol. Trace Elem. Res., 2007, 116, 81-89.
114. Qu, W.J.; Zhong, D.B.; Wu, P.F.; Wang, J.F.; Han, B. Sodium fluoride modulates caprine osteoblast proliferation and differentiation. J. Bone Miner. Metab., 2008, 26, 328-334.
115. Saravanapavan, P.; Jones, J.R.; Verrier, S.; Beilby, R.; Shirtliff, V.J.; Hench, L.L.; Polak, J.M. Binary CaO-SiO2 gel-glasses for biomedical applications. Biomed. Mater. Eng., 2004, 14, 467-486.
116. Bergandi, L.; Aina, V.; Garetto, S.; Malavasi, G.; Aldieri, E.; Laurenti, E.; Matera, L.; Morterra, C.; Ghigo, D. Fluoridecontaining bioactive glasses inhibit pentose phosphate oxidative pathway and glucose 6-phosphate dehydrogenase activity in human osteoblasts. Chem. Biol. Interact., 2010, 183, 405-415.
117. Luzzatto, L.; Afolayan, A. Enzymic properties of different types of human erythrocyte glucose-6-phosphate dehydrogenase, with characterization of two new genetic variants. J. Clin. Invest., 1968, 47, 1833-1842.
118. Aust, A.E.; Eveleigh, J.F. Mechanisms of DNA oxidation. Proc. Soc. Exp. Biol. Med., 1999, 222, 246-252.
119. Finkel, T. Signal transduction by reactive oxygen species in nonphagocytic cells. J. Leukoc. Biol., 1999, 65, 337-340.
120. Haase, H.; Maret, W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals, 2005, 18, 333-338.
121. Tonks, N.K. Redox redux: revisiting PTPs and the control of cell signaling. Cell, 2005, 121, 667-670.
122. Rhee, S.G.; Chang, T.S.; Bae, Y.S.; Lee, S.R.; Kang, S.W. Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol., 2003, 14, S211-S215.
123. Ushio-Fukai, M. Vascular signaling through G protein-coupled receptors: new concepts. Curr. Opin. Nephrol. Hypertens., 2009, 18, 153-159.
124. Sundaresan, M.; Yu, Z.X.; Ferrans, V.J.; Sulciner, D.J.; Gutkind, J.S.; Irani, K.; Goldschmidt-Clermont, P. J.; Finkel, T. Regulation of reactive oxygen species generation in fibroblasts by rac1. Biochem. J., 1996, 318, 379-382.
125. Irani, K.; Xia, Y.; Zweier, J.L.; Scollott, S.J.; Der, C.J.; Fearon, E.R.; Sundaresan, M.; Finkel, T.; Goldschmidt-Clermont, P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science, 1997, 275, 1649-1652.
126. McCubrey, J.A.; LaHair, M.M.; Franklin, R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal., 2006, 8, 1775-1789.
127. Yagoda, N.; von Rechenberg, M.; Zaganjor, E.; Bauer, A.J.; Yang, W.S.; Fridman, D.J.; Wolpaw, A.J.; Smukste, I.; Peltier, J.M.; Boniface, J.J.; Smith, R.; Lessnick, S.L.; Sahasrabudhe, S.; Stockwell, B.R. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature, 2007, 447, 864-868.
128. Jiang, H.; Zhang, L.; Koubi, D.; Kuo, J.; Groc, L.; Rodriguez, A.I.; Hunter, T.J.; Tang, S.; Lazarovici, P.; Gautam, S.C.; Levine, R.A. Roles of Ras-Erk in apoptosis of PC12 cells induced by trophic factor withdrawal or oxidative stress. J. Mol. Neurosci., 2005, 25, 133-140.
129. Misra, U.K.; Gawdi, G.; Pizzo, S.V. Beryllium fluoride-induced cell proliferation: a process requiring P21ras-dependent activated signal transduction and NF-kB-dependent gene regulation. J. Leukoc. Biol., 2002, 71, 487-494.
130. Zhang, M.; Wang, A.; Xia, T.; He, P. Effects of fluoride on DNA damage, S-phase cell-cycle arrest and the expression of NF-kB in primary cultured rat hippocampal neurons. Toxicol. Lett., 2008, 179, 1-5.
131. Isa, Z.M.; Schneider, G.B.; Zaharias, R.; Seabold, D.; Stanford, C.M. Effects of fluoride-modified titanium surfaces on osteoblast proliferation and gene expression. Int. J. Oral Maxillofac. Implants, 2006, 21, 203-211.
132. Cooper, L.F.; Zhou, Y.; Takebe, J.; Guo, J.; Abron, A.; Holmén, A.; Ellingsen, J.E. Fluoride modification effects on osteoblast behavior and bone formation at TiO2 grit-blasted c.p. titanium endosseous implants. Biomaterials, 2006, 27, 926-936.
133. Guo, J.; Padilla, R.J.; Ambrose, W.; De Kok, I.J.; Cooper, L.F. The effect of hydrofluoric acid treatment of TiO2 grit blasted titanium implants on adherent osteoblast gene expression in vitro and in vivo. Biomaterials, 2007, 28, 5418-5425.
134. Lamolle, S.F.; Monjo, M.; Rubert, M.; Haugen, H.J.; Lyngstadaas, S.P.; Ellingsen, J.E. The effect of hydrofluoric acid treatment of titanium surface on nanostructural and chemical changes and the growth of MC3T3-E1 cells. Biomaterials, 2009, 30, 736-742.